Advertisementspot_img
Saturday, November 23, 2024

Delivering Stories of Progress

Advertisementspot_img

TAG

PAXLOVID

FDA Approves Emergency Use Authorization (EUA) for Pfizer’s COVID-19 Oral Treatment in Phl

Data demonstrated an 89% and 88% reduction in risk of COVID-19-related hospitalization or death from any cause in adults treated with PAXLOVID within three...

Latest news